Bryan Paul Morgan - Curriculum Vitae#

B. Paul Morgan, BSc, MB BCh, PhD, FRCPath, MRCP, FMedSci

Accreditation: Chemical Pathology
Clinically active

Degrees, diplomas and honours:
  • 1977 BSc. (1st Class Hons) Medical Biochemistry. 1980 MBBCh. (Wales). 1984 PhD. (Wales)
  • 1988 Membership of the Royal College of Pathologists (MRCPath)
  • 1997 Fellowship of the Royal College of Pathologists (FRCPath)
  • 1999 Elected Fellow Academy of Medical Sciences (FMedSci)
  • 2000 Elected Member Royal College of Physicians (MRCP)
  • 2001 Elected Member Association of Physicians.
  • 2005-2008 Council Member, Academy of Medical Sciences
  • 2011- Council Member, Medical Research Council

National/International bodies:
  • Council Member Academy of Medical Sciences (2005-2008)
  • Member AcMedSci committee on MB PhD schemes
  • Member AcMedSci Academic Careers Committee
  • Member RAE 2008 sub-panel A3 (Infection and Immunity)
  • Meetings Secretary, Treasurer, Trustee and Councillor, British Society for Immunology. International Complement Society Committee (2003-13 ); Chair 2011-2013
  • Chair, European Complement Network (2001-2007)
  • Chair, Grants Review Committee, NISCHR (2013 - )

Current Grant support:

Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer’s Disease. 2015-2020. Value £5.7M (app. £0.5M to Cardiff). Lead for inflammatory biomarkers theme.
BBSRC CASE Studentship with GSK; 2015-2018; Value: app. £160,000. Title: “Signalling non-lethal effects of the membrane attack complex”.
MS Society Studentship 2012-2015; Value £104,350. Title: “Mechanisms and roles of microglial priming and activation in experimental demyelination and human MS”.
BBSRC CASE Studentship with GSK; 2012-2016; Value: app. £150,000. Title: “Mechanisms responsible for differential bactericidal activities of human and rabbit complement against Neisseria meningitidis”.
Fight for Sight Project Grant; 2013-2015; Value: £169,937. Title: 'The complotype as a predictor of disease and response to therapy in AMD'.
BHF Project Grant; 2013-2016; Value; £297,000. Title: “The role of complement dysregulation and C3adesArg in atherosclerosis".
Imprint Privacy policy « This page (revision-2) was last changed on Tuesday, 27. October 2015, 09:18 by Kaiser Dana
  • operated by